Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy.
about
Heart rate variability biofeedback: how and why does it work?Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathyNon-pharmacological modulation of the autonomic tone to treat heart failureCholinergic activity as a new target in diseases of the heartSimulation of Cardiac Arrhythmias Using a 2D Heterogeneous Whole Heart ModelPriming the proteasome by protein kinase G: a novel cardioprotective mechanism of sildenafilDrug-induced adverse events prediction with the LINCS L1000 dataEffect of tDCS with an extracephalic reference electrode on cardio-respiratory and autonomic functions.Correlation of Ventricular Arrhythmogenesis with Neuronal Remodeling of Cardiac Postganglionic Parasympathetic Neurons in the Late Stage of Heart Failure after Myocardial InfarctionDiabetic cardiomyopathy: where we are and where we are going.Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure.Cytisine induces autonomic cardiovascular responses via activations of different nicotinic receptors.Pyridostigmine restores cardiac autonomic balance after small myocardial infarction in miceIntermittent Atrioventricular Block following Fingolimod Initiation.The role of muscarinic receptors in the beneficial effects of adenosine against myocardial reperfusion injury in rats.Tachycardia, reduced vagal capacity, and age-dependent ventricular dysfunction arising from diminished expression of the presynaptic choline transporter.A healthy heart is not a metronome: an integrative review of the heart's anatomy and heart rate variabilityAn analysis of the myocardial transcriptome in a mouse model of cardiac dysfunction with decreased cholinergic neurotransmission.New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association.25-hydroxyvitamin D and its relationship with autonomic dysfunction using time- and frequency-domain parameters of heart rate variability in Korean populations: a cross-sectional study.Maternal diet-induced obesity programs cardiovascular dysfunction in adult male mouse offspring independent of current body weightHeart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatmentRelationship between diastolic function and heart rate recovery after symptom-limited exercise.Regulation of Cardiac Autonomic Nervous System Control across Frailty Statuses: A Systematic ReviewEvidence of increased cardiac parasympathetic drive in subjects meeting current physical activity recommendations.Changes in Autonomic Nervous System Activity are Associated with Changes in Sexual Function in Women with a History of Childhood Sexual Abuse.The effect of the sphingosine-1-phosphate analogue FTY720 on atrioventricular nodal tissue.Post-Exercise Heart Rate Recovery Independently Predicts Clinical Outcome in Patients with Acute Decompensated Heart Failure.Intermittent electrical stimulation of the right cervical vagus nerve in salt-sensitive hypertensive rats: effects on blood pressure, arrhythmias, and ventricular electrophysiology.Mesenchymal Stem Cells Improve Heart Rate Variability and Baroreflex Sensitivity in Rats with Chronic Heart FailurePilot Investigation of PTSD, Autonomic Reactivity, and Cardiovascular Health in Physically Healthy Combat Veterans.Clinical Application of the Heart Rate Deceleration Capacity Test to Predict Epirubicin-induced CardiotoxicityVagal nerve stimulation reduces anterior mitral valve leaflet stiffness in the beating ovine heart.Control of ventricular excitability by neurons of the dorsal motor nucleus of the vagus nerve.Central-peripheral neural network interactions evoked by vagus nerve stimulation: functional consequences on control of cardiac functionReduced vagal control of the heart in high-fat diet mice: a potential role of increased butyrylcholinesterase.Age-related attenuation of parasympathetic control of the heart in mice.Deceleration and acceleration capacities of heart rate associated with heart failure with high discriminating performance.Caffeine Enhances Heart Rate Variability in Middle-Aged Healthy, But Not Heart Failure Subjects.Current treatment of heart failure with preserved ejection fraction: should we add life to the remaining years or add years to the remaining life?
P2860
Q21129132-58A0C45A-EB0F-44E0-8428-2160A1F681CCQ26775037-442551A9-61D3-4A95-9F67-61AFDF11A7C5Q26822899-60BA7DA9-CDE2-467B-A0BD-9252101EA17CQ27004543-779FDC21-979E-4E4B-A2FF-4E1469D7340EQ27307949-F18E7A0C-DF42-4C4E-9732-CDD2E9DE4B45Q28084015-72039941-A873-4FAD-BBE3-24F7834F59CAQ31092242-B5C3D95D-7AE6-4AE0-90EC-DFEF74EE6995Q33541314-F398531F-B17A-4968-8508-A413313898ECQ33645818-35B4543B-B7B8-48DA-91DB-DC389EFB24C7Q33690717-EB7D5381-60D6-45CC-9655-798729CC63C4Q33725534-CD7C2818-EC52-480B-B149-DE8E60B66053Q33751042-35558D7B-7DA7-4EC9-88AB-C35AC8BCD5F3Q34061367-ACCF835A-7090-414A-B5E5-587BABAF81EDQ34069400-6DF6682A-151D-41CA-AD2D-A9FF8A69DD31Q34071490-386503E7-23F8-4168-B580-18F2BAF4D3DAQ34150552-DF6528C6-DECC-4C33-9679-19C001B2DCF6Q34265500-303C5882-25C6-411F-BD8C-7189A35EE615Q34328505-83A93541-51B6-431F-9B46-3644296543B2Q34387086-972C6AFE-916B-4471-8F5F-1EC36BE64C59Q34411710-09D03634-46BE-43A7-BA5A-5DA6DE9FA8F0Q34628879-E9B6F8CA-8186-4DC6-ACB8-2AB92DCE308EQ34664894-4B48765F-8CDE-4B71-9141-C2A1164E39A8Q35634537-76ECD01B-193A-441B-9FA0-390F37176772Q35687317-3B35B929-1C76-4714-9EF0-13DC1428F188Q35770273-4CB3D77A-5CC3-4A16-B307-1DA2FFF37B0AQ35875593-EAF91313-56DB-411D-843E-17444DA60C56Q35879566-4CB7CE95-285E-4C30-B60B-115333D8DE07Q36005022-6B6C7AAF-52CE-4647-8BB5-F9762A1138F3Q36036399-7A6FD9AA-6210-4E57-A660-164F7E9281DBQ36074040-BB568E9D-ECEF-49DF-A6E6-D07E659639FAQ36126499-9DBE61AB-1C4C-4E01-AC61-29450B6A34A4Q36136774-E9A1BD05-9864-487E-AB24-15C6A1C2E0B9Q36176704-5835EB98-75E7-415E-B3EB-B1E2DC24F366Q36245239-9BDBB925-692F-4CA0-AC0A-EAAC4467EAC8Q36339480-42B56ADD-E425-444D-8CC2-1EC7DC6F8C3DQ36357537-EF91F9AF-A1DE-402F-832F-3A4F9351FE8EQ36420103-E585D15A-748F-4DF2-8BB7-6C96B7F98B53Q36719531-AC64E1E7-2C7B-4A77-9671-14BCFDBEB2BAQ36752602-65E0EB66-0592-4288-845A-253402D552E5Q37292234-0CC429D0-48D3-41AA-8D50-FCA40D97E5AC
P2860
Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Parasympathetic nervous system ...... tial implications for therapy.
@en
Parasympathetic nervous system ...... tial implications for therapy.
@nl
type
label
Parasympathetic nervous system ...... tial implications for therapy.
@en
Parasympathetic nervous system ...... tial implications for therapy.
@nl
prefLabel
Parasympathetic nervous system ...... tial implications for therapy.
@en
Parasympathetic nervous system ...... tial implications for therapy.
@nl
P2093
P1433
P1476
Parasympathetic nervous system ...... tial implications for therapy.
@en
P2093
Brian Olshansky
Hani N Sabbah
Paul J Hauptman
Wilson S Colucci
P304
P356
10.1161/CIRCULATIONAHA.107.760405
P407
P577
2008-08-01T00:00:00Z